ARCHIVES

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

This article is from The Cancer Letter archive.

Vol. 37 No. 40 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Women Surgeons: We Need Answers On Tamoxifin Now

May 13, 1994

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

Cooperative Group Chairmen, OPRR Seek Agreement On Assurances

January 6, 1984

Mihich to Be Sixth New NCAB appointee; Centers Worried About Core Grants, Role In 200 AD Goals

May 25, 1984

NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database

October 11, 1996

Interview with Mark Ratain: Too Much Emphasis On Precision, Not Enough Emphasis On Accuracy In Dosing

October 8, 2010